116 related articles for article (PubMed ID: 2284196)
1. A new highly potent antagonist of bradykinin.
Lammek B; Wang YX; Gavras I; Gavras H
Peptides; 1990; 11(5):1041-3. PubMed ID: 2284196
[TBL] [Abstract][Full Text] [Related]
2. A novel bradykinin antagonist with improved properties.
Lammek B; Wang YX; Gavras I; Gavras H
J Pharm Pharmacol; 1991 Dec; 43(12):887-8. PubMed ID: 1687595
[TBL] [Abstract][Full Text] [Related]
3. The effect of a bradykinin antagonist on vasodilator responses with particular reference to the submandibular gland of the cat.
Barton S; Karpinski E; Schachter M
Experientia; 1988 Oct; 44(10):897-8. PubMed ID: 3181375
[TBL] [Abstract][Full Text] [Related]
4. Edematous response caused by [Thi5,8,D-Phe7]bradykinin, a B2 receptor antagonist, is due to mast cell degranulation.
Wang JP; Hsu MF; Ouyang CH; Teng CM
Eur J Pharmacol; 1989 Feb; 161(2-3):143-9. PubMed ID: 2640560
[TBL] [Abstract][Full Text] [Related]
5. New, long-acting, potent bradykinin antagonists.
Lembeck F; Griesbacher T; Eckhardt M; Henke S; Breipohl G; Knolle J
Br J Pharmacol; 1991 Feb; 102(2):297-304. PubMed ID: 2015416
[TBL] [Abstract][Full Text] [Related]
6. HOE 140, a new highly potent and long-acting bradykinin antagonist in conscious rats.
Bao G; Qadri F; Stauss B; Stauss H; Gohlke P; Unger T
Eur J Pharmacol; 1991 Jul; 200(1):179-82. PubMed ID: 1769370
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of endopeptidase-24.15 decreases blood pressure in normotensive rats.
Genden EM; Molineaux CJ
Hypertension; 1991 Sep; 18(3):360-5. PubMed ID: 1889849
[TBL] [Abstract][Full Text] [Related]
8. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies.
Hock FJ; Wirth K; Albus U; Linz W; Gerhards HJ; Wiemer G; Henke S; Breipohl G; König W; Knolle J
Br J Pharmacol; 1991 Mar; 102(3):769-73. PubMed ID: 1364851
[TBL] [Abstract][Full Text] [Related]
9. Effect of bradykinin on opossum esophageal longitudinal smooth muscle: evidence for novel bradykinin receptors.
Saha JK; Sengupta JN; Goyal RK
J Pharmacol Exp Ther; 1990 Mar; 252(3):1012-20. PubMed ID: 2156987
[TBL] [Abstract][Full Text] [Related]
10. A study of the action of bradykinin and bradykinin analogues in the human nasal airway.
Austin CE; Foreman JC
J Physiol; 1994 Jul; 478 ( Pt 2)(Pt 2):351-6. PubMed ID: 7965850
[TBL] [Abstract][Full Text] [Related]
11. Competitive analog antagonists of bradykinin in the canine hindlimb.
Beierwaltes WH; Carretero OA; Scicli AG; Vavrek RJ; Stewart JM
Proc Soc Exp Biol Med; 1987 Oct; 186(1):79-83. PubMed ID: 3628255
[TBL] [Abstract][Full Text] [Related]
12. [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
Farmer SG; Burch RM; Dehaas CJ; Togo J; Steranka LR
J Pharmacol Exp Ther; 1989 Feb; 248(2):677-81. PubMed ID: 2537408
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin receptor antagonists used to characterize the heterogeneity of bradykinin-induced responses in rat vas deferens.
Rifo J; Pourrat M; Vavrek RJ; Stewart JM; Huidobro-Toro JP
Eur J Pharmacol; 1987 Oct; 142(2):305-12. PubMed ID: 2891546
[TBL] [Abstract][Full Text] [Related]
14. Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells.
Bueb JL; Mousli M; Bronner C; Rouot B; Landry Y
Mol Pharmacol; 1990 Dec; 38(6):816-22. PubMed ID: 1701214
[TBL] [Abstract][Full Text] [Related]
15. New bradykinin analogues modified in the C-terminal part with sterically restricted 1-aminocyclohexane-1-carboxylic acid.
Labudda-Dawidowska O; Wierzba TH; Prahl A; Kowalczyk W; Gawiński Ł; Plackova M; Slaninová J; Lammek B
J Med Chem; 2005 Dec; 48(25):8055-9. PubMed ID: 16335929
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the bradykinin receptor in the human nasal airway using the binding of [125I]-Hoe 140.
Dear JW; Wirth K; Scadding GK; Foreman JC
Br J Pharmacol; 1996 Nov; 119(5):1054-62. PubMed ID: 8922758
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin receptor blockade does not affect oxygen-mediated pulmonary vasodilation in fetal lambs.
Banerjee A; Roman C; Heymann MA
Pediatr Res; 1994 Oct; 36(4):474-80. PubMed ID: 7816523
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of Hoe 140 on vasodilator responses to bradykinin in the mesenteric vascular bed of the cat.
Santiago JA; Osei SY; Kadowitz PJ
Eur J Pharmacol; 1993 May; 236(2):315-8. PubMed ID: 8319757
[TBL] [Abstract][Full Text] [Related]
19. Central B2 receptor involvement in the antinociceptive effect of bradykinin in rats.
Pelá IR; Rosa AL; Silva CA; Huidobro-Toro JP
Br J Pharmacol; 1996 Jul; 118(6):1488-92. PubMed ID: 8832076
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3,Thi5,D-Tic7,Qic8]bradykinin).
Rhaleb NE; Rouissi N; Jukic D; Regoli D; Henke S; Breipohl G; Knolle J
Eur J Pharmacol; 1992 Jan; 210(2):115-20. PubMed ID: 1601053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
